SARC-OLD: Diet in Elderly With Type 2 Diabetes

Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05961878
Collaborator
(none)
100
1
2
23
4.3

Study Details

Study Description

Brief Summary

Sarcopenia is characterized by progressive and generalized loss of skeletal muscle mass which may affect performance. Diabetes can affect muscle cell function, making sarcopenia worse.

This is a prospective and interventional study on a elderly population affected by type 2 diabetes mellitus. All subjects, recruited will undergo tests for the diagnosis of sarcopenia according to the EWGSOP2 criteria. All subjects, both sarcopenic and non-sarcopenic, will be introduced to a targeted nutritional program aimed at improving the composition of the diet, in terms of both micro- and macro-nutrients.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: mediterranean diet with adequate protein intake
N/A

Detailed Description

The sample will consist of about 100 subjects (50 sarcopenic and 50 non-sarcopenic) who receive the nutritional program. Particular attention will be paid to the intake of an adequate protein intake for the elderly subject (1.1 g/kg/day). A food diary will be required to assess daily protein-calorie intake and questionnaires to assess daily physical activity and quality of life.

The primary objective is to assess the efficacy of nutritional intervention in elderly affected by type 2 diabetes mellitus and sarcopenia. The secondary objective is to identify the prevalence of sarcopenia in patients with type 2 diabetes mellitus compared to non-diabetic subjects and to verify the relationship between pharmacological therapy and the presence of sarcopenia as well as evaluate any changes in style and quality of life and of glycometabolic compensation.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Efficacy of Diet in Elderly With Type 2 Diabetes
Anticipated Study Start Date :
Jul 31, 2023
Anticipated Primary Completion Date :
Jun 1, 2024
Anticipated Study Completion Date :
Jul 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Sarcopenic

subjects with sarcopenia diagnosis

Dietary Supplement: mediterranean diet with adequate protein intake
balanced mediterranean diet with 1.1 g/kg die protein intake

Placebo Comparator: Non sarcopenic

subjects without sarcopenia diagnosis

Dietary Supplement: mediterranean diet with adequate protein intake
balanced mediterranean diet with 1.1 g/kg die protein intake

Outcome Measures

Primary Outcome Measures

  1. Handgrip test [1 years]

    Increase of hand grip strength (units: kg)

Secondary Outcome Measures

  1. Glycemic control [1 year]

    HbA1c (units: mmol/mol)

  2. Anthropometric parameters: BIOIMPEDENTIOMETRIC PARAMETERS [1 year]

    fat mass and free fat mass (units: % of total mass)

  3. Dietary lifestyle [1 year]

    variations in intake of simple sugars, animal protein rich foods, saturated fats and cholesterol, UDM: grams/die. All the informations will be collected using 5days food diaries, completed by the patients

Other Outcome Measures

  1. health-related quality of life [1 year]

    assesed Sacopenia Quality of life (SarQoL)

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years to 95 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Type 2 Diabetes

  • BMI >20 kg/m2

  • HbA1c ≥6.5% (48 mmol/mol) e ≤10% (86 mmol/mol)

Exclusion Criteria:
  • T1DM or LADA

  • Patients with serious primary diseases of heart, brain, liver, kidney and hematopoietic system

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy 20122

Sponsors and Collaborators

  • Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Emanuela Orsi, medical doctor, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
ClinicalTrials.gov Identifier:
NCT05961878
Other Study ID Numbers:
  • Sarcopenia-diabetes
First Posted:
Jul 27, 2023
Last Update Posted:
Jul 27, 2023
Last Verified:
Jul 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 27, 2023